Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy

Europace

Volumn 9, Issue 11, 2007, Pages 1031-1037

  Chalil, Shajil ^a   Foley, Paul W X ^a   Muyhaldeen, Sarkaw A ^a   Patel, Kiran C R ^b   Yousef, Zaheer R ^a   Smith, Russell E A ^a   Frenneaux, Michael P ^a   Leyva, Francisco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b City and Sandwell Hospitals   (United Kingdom)

Author keywords

Cardiac resynchronization therapy; Cardiovascular magnetic resonance; Heart failure; Myocardial viability

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE; LOOP DIURETIC AGENT; SPIRONOLACTONE; GADOLINIUM;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITALIZATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCAR FORMATION; TREATMENT RESPONSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALKING SPEED; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TOLERANCE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PACING; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; SCAR; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; CICATRIX; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; GADOLINIUM; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 40049084699     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum133     Document Type: Article

References (28)

1. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L. et al. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-49.
2. Abraham WT, Fisher WG, Smith AL, Deluergio DB, Leon AR, Kocovic DZ, et al., for the MIRACLE study group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
3. Cazeau S, Leclercq C, Lavergene T, Walker S, Varma C, Linde C. et al., for the Multistimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001;344:873-80.
4. Kass DA. Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med 2003;4:S3-13.
5. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003;91:684-8.
6. Yu CM, Yang H, Lau CP, Wang Q, Wang S, Lam L. et al. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol 2003;26:562-570.
7. Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M. et al. Predictors of systolic augmentation from left ventricular pre excitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000;101:2703-9.
8. Søgaard P, Kim WK, Jensen HK, Mortensen P, Pedersen AK, Kristensen BO. et al. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure. A tissue Doppler and three dimensional echocardiographic study. Cardiology 2001;95:173-82.
9. Søgaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BO. et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.
10. Depre C, Vanoverschelde JL, Melin JA, Borgers M, Bol A, Ausma J. et al. Structural and metabolic correlates of reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-75.
11. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A. et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76.
12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
13. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M. et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
14. Guyatt GH, Sullivan MJ, Thompson PJ. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.
15. Rector TS, Kubo SH, Cohn JN. Patient's self-assessment of their congestive heart failure. Content, reliability and validity of a new measure - The Minnesota living with heart failure questionnaire. Heart Failure 1987;3:198-207.
16. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace 1999;1:126-30.
17. Albertsen AE, Nielsen JC, Pedersen AK, Hansen PS, Jensen HK, Mortensen PT. Left ventricular lead performance in cardiac resynchronization therapy: impact of lead localization and complications. Pacing Clin Electrophysiol 2005;28:483-8.
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council of the American Heart Association. Circulation 2002;105:539-42.
19. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Col Cardiol 2002;39:1151-8.
20. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kin RJ. Visualisation of presence, location and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28.
21. Kim RJ, Wu E, Rafael A, Chen E-L, Parker MA, Simonetti O, Klocke FJ, Bonow RO, and Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
22. Bellenger NG, Yousef Z, Kajappan K, Marber MS, Pennell DJ. Infarct viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery. Heart 2005;91:478-83.
23. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker MA, Johnson M. et al. Gadolinium cardiovascular magnetic resonance predicts myocardial dysfunction and remodelling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-53.
24. Meluzin J, Cerny J, Frelich M, Stetka F, Spiranova F, Popelova J. et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Col Cardiol 1998;32:912-20.
25. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB. et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
26. White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M. et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006;48:1953-60.
27. Reddy VY, Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN. Combined epicardial and endocardial electroanatomic mapping in a porcine model of healed myocardial infarction. Circulation 2003; 107:3236-42.
28. Schwartzman D, Chang I, Michele JJ, Moritznik MS, Foster KR. Electrical impedance properties of normal and chronically infarcted ventricular myocardium. J Interv Card Electrophysiol 1999;3:213-24.